Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 31 out of 100. Clinical safety

Topic: Brain proteins, microglia and lab models

Sundowning Syndrome (SS) is a clinically observed phenomenon, primarily associated with Alzheimer’s disease (AD), characterized by the exacerbation of neuropsychiatric symptoms during the late afternoon or evening, or in conditions of reduced ambient illumination. These symptoms may include, but are not limited to, agitation, anxiety, confusion, hallucinations, and altered sleep-wake cycles. The absence of a universally accepted definition and standardized diagnostic criteria contributes to inconsistencies in clinical assessment and research. Diagnostic approaches frequently utilize behavioral rating scales, such as the Cohen-Mansfield Agitation Inventory and the Neuropsychiatric Inventory (NPI), which are often caregiver-reported. A proposed operational definition emphasizes the acute onset of disruptive behavioral changes in individuals with dementia during evening hours, with a focus on symptoms that significantly impact caregiving. Environmental modifications, particularly optimized ambient lighting, are considered a key nonpharmacological intervention for symptom management. In this work, we present an interesting case report of a patient who developed SS following hospitalization in a thoracic surgery unit for a pneumothorax complicated by subcutaneous emphysema. The emphysema extended from the thorax to the face, involving the periorbital region and resulting in the patient’s inability to open their eyes. This sensory deafferentation triggered the onset of symptoms associated with SS in a patient with no prior history of psychiatric disorders.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Fraccalini, T., TAROZZO, B., Maraschi, A., CARDINALE, L., Garofalo, G., Vecchini, J. M., et al. (2025). Air under the skin, shadows in the mind: an enigmatic case report on hyperactive delirium or Sundowning triggered by subcutaneous emphysema postpneumothorax. Minerva Psychiatry. https://doi.org/10.23736/s2724-6612.25.02639-9

Vancouver

Fraccalini T, TAROZZO B, Maraschi A, CARDINALE L, Garofalo G, Vecchini JM, et al. Air under the skin, shadows in the mind: an enigmatic case report on hyperactive delirium or Sundowning triggered by subcutaneous emphysema postpneumothorax. Minerva Psychiatry. 2025. doi:10.23736/s2724-6612.25.02639-9.

BibTeX

@article{fraccalini2025-994cdaf0,
  author  = {Fraccalini, Thomas and TAROZZO, Beatrice and Maraschi, Alessandro and CARDINALE, Luciano and Garofalo, Giorgio and Vecchini, Julia Michelin and RIBEIRO, Laura SANTOS and Gioia, Stefania and others},
  title   = {{Air under the skin, shadows in the mind: an enigmatic case report on hyperactive delirium or Sundowning triggered by subcutaneous emphysema postpneumothorax}},
  journal = {Minerva Psychiatry},
  year    = {2025},
  doi     = {10.23736/s2724-6612.25.02639-9},
  url     = {https://doi.org/10.23736/s2724-6612.25.02639-9}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This is a single case report of a patient who developed Sundowning Syndrome following hospitalization for a pneumothorax complicated by subcutaneous emphysema. As a case report, it cannot establish causation or provide generalizable evidence about treating, curing, or preventing Alzheimer's disease.

Study details

How this study scored 31/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 31 of 100.31 of 100 points earned69 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Minerva Psychiatry)
Journal's citation record 0 / 4 Minerva Psychiatry: journal h-index 9 (OpenAlex, 2026-10-29)
Study design 0 / 12 Design recorded as “case report”, which our rubric does not rank (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Giovanni Volpicelli: h-index 5 (OpenAlex, whole career)
Institution's track record 2 / 3 University College London: institution h-index 2,029 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 7 institution(s) in 2 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 31 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Clinical safety

Also tagged “small”

900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Clinical safety

See all studies in Clinical safety →